基于网络的干预对1型和2型糖尿病成人抑郁症状的成本效果评价
该研究基于一项纳入260名参与者的随机对照试验,对GET.ON M.E.D.网络干预与主动对照组(网络心理教育)进行成本效果分析(结局为治疗反应)和成本效用分析(结局为QALY)。结果显示,在支付意愿上限为5000欧元时,干预具有97%的概率被视为具有成本效果;
要点
- 网络干预GET.ON M.E.D.在治疗反应方面具有高概率成本效果(支付意愿5000欧元时97%)。
- 利益冲突声明:多名作者为在线健康培训研究所的利益相关者。
核心结论
- 与主动对照组相比,该网络干预在糖尿病共病抑郁个体中显示出高概率的成本效果。
研究设计与样本
- 基于随机对照试验的成本效果分析(结局为治疗反应)和成本效用分析(结局为QALY),共纳入260名参与者。
主要发现
- 在支付意愿上限为5000欧元时,干预具有97%的概率被视为具有成本效果。
关键数值与推荐
- 治疗反应的成本效果概率:支付意愿5000欧元时为97%。
临床怎么用
- 对于伴有抑郁的1型和2型糖尿病成人,基于网络的干预可作为具有成本效果潜力的治疗选择。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Web-based interventions are effective in reducing depression. However, the evidence for the cost-effectiveness of these interventions is scarce.AimsThe aim is to assess the cost-effectiveness of a web-based intervention (GET.ON M.E.D.) for individuals with diabetes and comorbid depression compared with an active control group receiving web-based psychoeducation. METHOD: We conducted a cost-effectiveness analysis with treatment response as the outcome and a cost-utility analysis with quality-adjusted life-years (QALYs) alongside a randomised controlled trial with 260 participants. RESULTS: At a willingness-to-pay ceiling of €5000 for a treatment response, the intervention has a 97% probability of being regarded as cost-effective compared with the active control group. If society is willing to pay €14 000 for an additional QALY, the intervention has a 51% probability of being cost-effective. CONCLUSIONS: This web-based intervention for individuals with diabetes and comorbid depression demonstrated a high probability of being cost-effective compared with an active control group.Declaration of interestS.N., D.D.E., D.L., M.B. and B.F. are stakeholders of the Institute for Online Health Trainings, which aims to transfer scientific knowledge related to this research into routine healthcare.
引用
- Nobis S, Ebert DD, Lehr D, et al. Web-based intervention for depressive symptoms in adults with types 1 and 2 diabetes mellitus: a health economic evaluation. Br J Psychiatry. 2018. PMID: 30071909. doi:10.1192/bjp.2018.10
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。